PLAY PODCASTS
Anthony Tennyson, Awakn Life Sciences
Episode 44

Anthony Tennyson, Awakn Life Sciences

Psychedelic Spotlight Podcast · David Flores, Awakn Life Sciences, Anthony Tennyson, Global Trac Solutions Inc., Psychedelic Spotlight

July 9, 202124m 24s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode of the Psychedelic Spotlight podcast, we feature Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction.

In our conversation with Anthony, we gain insight on Awakn's psychedelic therapy delivery activities, the company's plans to expand across the EU, and what the addition of renowned neuroscientist, Professor David Nutt as their Chief Research Officer means to their ongoing growth initiatives.

*To learn more about the company featured in this episode and the work they’re doing, visit their website: AwaknLifeSciences.com

*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. 

Visit our Website: PsychedelicSpotlight.com

Subscribe to our YouTube Channel

Follow us on Instagram

Like us on Facebook

Follow us on Twitter

*This episode was recorded on June 30, 2021.

Topics

david floresmdmaglobal trac solutions incpsychedelic-assisted psychotherapypsychotherapistayahuascaketamineawakn life sciencespsychotherapymeditationmushroomsyogashroomsmagic shroomsmental healthhealthpsilocybinpsychedelic spotlightanthony tennysonketamine-assisted psychotherapyplant medicinepsychedelics